123 related articles for article (PubMed ID: 35123611)
1. [The Relationship between MicroRNA Expression Profiling in Imatinib-Resistant Cell Line K562/G and Potential Mechanism through FOXO3/Bcl-6 Signaling Pathway].
Shen J; Wang H; Wang JS; Wei N; Wang Z
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):107-112. PubMed ID: 35123611
[TBL] [Abstract][Full Text] [Related]
2. Identifying and validating a combined mRNA and microRNA signature in response to imatinib treatment in a chronic myeloid leukemia cell line.
Bhutra S; Lenkala D; LaCroix B; Ye M; Huang RS
PLoS One; 2014; 9(12):e115003. PubMed ID: 25506832
[TBL] [Abstract][Full Text] [Related]
3. MiRNA-96-5p contributed to the proliferation of gastric cancer cells by targeting FOXO3.
He X; Zou K
J Biochem; 2020 Jan; 167(1):101-108. PubMed ID: 31598681
[TBL] [Abstract][Full Text] [Related]
4. miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes.
Farhadi E; Zaker F; Safa M; Rezvani MR
Tumour Biol; 2016 Oct; 37(10):14117-14128. PubMed ID: 27517565
[TBL] [Abstract][Full Text] [Related]
5. LncRNA highly upregulated in liver cancer regulates imatinib resistance in chronic myeloid leukemia via the miR-150-5p/MCL1 axis.
Han Y; Ma Z
Anticancer Drugs; 2021 Apr; 32(4):427-436. PubMed ID: 33587348
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA 195-5p Targets
Bai Y; Pan B; Zhan X; Silver H; Li J
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201585
[TBL] [Abstract][Full Text] [Related]
7. De-regulated STAT5A/miR-202-5p/USP15/Caspase-6 regulatory axis suppresses CML cell apoptosis and contributes to Imatinib resistance.
Nie ZY; Yao M; Yang Z; Yang L; Liu XJ; Yu J; Ma Y; Zhang N; Zhang XY; Liu MH; Jiang LL; Luo JM
J Exp Clin Cancer Res; 2020 Jan; 39(1):17. PubMed ID: 31952546
[TBL] [Abstract][Full Text] [Related]
8. Circ_0009910 promotes imatinib resistance through ULK1-induced autophagy by sponging miR-34a-5p in chronic myeloid leukemia.
Cao HX; Miao CF; Sang LN; Huang YM; Zhang R; Sun L; Jiang ZX
Life Sci; 2020 Feb; 243():117255. PubMed ID: 31923418
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-29c-3p participates in insulin function to modulate polycystic ovary syndrome via targeting Forkhead box O 3.
Chen H; Fu Y; Guo Z; Zhou X
Bioengineered; 2022 Feb; 13(2):4361-4371. PubMed ID: 35142592
[TBL] [Abstract][Full Text] [Related]
10. Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted "hsa-miR-2278" as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A.
Kaymaz BT; Günel NS; Ceyhan M; Çetintaş VB; Özel B; Yandım MK; Kıpçak S; Aktan Ç; Gökbulut AA; Baran Y; Can BK
Tumour Biol; 2015 Sep; 36(10):7915-27. PubMed ID: 25953263
[TBL] [Abstract][Full Text] [Related]
11. [CRISPR/Cas9-mediated microRNA-21 knockout increased imatinib sensitivity in chronic myeloid leukemia cells].
Zhang Y; Wang LY; Li JZ; Jiang PF; Hu JD; Chen BY
Zhonghua Xue Ye Xue Za Zhi; 2021 Mar; 42(3):243-249. PubMed ID: 33910311
[No Abstract] [Full Text] [Related]
12. MicroRNA-30c-5p inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis through FOXO3 down-regulation in atherosclerosis.
Li P; Zhong X; Li J; Liu H; Ma X; He R; Zhao Y
Biochem Biophys Res Commun; 2018 Sep; 503(4):2833-2840. PubMed ID: 30119891
[TBL] [Abstract][Full Text] [Related]
13. Identification of microRNA-regulated pathways using an integration of microRNA-mRNA microarray and bioinformatics analysis in CD34+ cells of myelodysplastic syndromes.
Xu F; Zhu Y; He Q; Wu LY; Zhang Z; Shi WH; Liu L; Chang CK; Li X
Sci Rep; 2016 Aug; 6():32232. PubMed ID: 27571714
[TBL] [Abstract][Full Text] [Related]
14. hsa-miR-9-3p and hsa-miR-9-5p as Post-Transcriptional Modulators of DNA Topoisomerase II
Kania EE; Carvajal-Moreno J; Hernandez VA; English A; Papa JL; Shkolnikov N; Ozer HG; Yilmaz AS; Yalowich JC; Elton TS
Mol Pharmacol; 2020 Mar; 97(3):159-170. PubMed ID: 31836624
[TBL] [Abstract][Full Text] [Related]
15. MiRNA-96-5p impacts the progression of breast cancer through targeting FOXO3.
Yin Z; Wang W; Qu G; Wang L; Wang X; Pan Q
Thorac Cancer; 2020 Apr; 11(4):956-963. PubMed ID: 32100957
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-155-5p facilitates enterovirus 71 replication through suppression of type I IFN response by targeting FOXO3/IRF7 pathway.
Yang D; Wang X; Gao H; Chen B; Si C; Wang S
Cell Cycle; 2020 Jan; 19(2):179-192. PubMed ID: 31856677
[TBL] [Abstract][Full Text] [Related]
17. MiR-155-5p promotes fibroblast cell proliferation and inhibits FOXO signaling pathway in vulvar lichen sclerosis by targeting FOXO3 and CDKN1B.
Ren L; Zhao Y; Huo X; Wu X
Gene; 2018 May; 653():43-50. PubMed ID: 29339071
[TBL] [Abstract][Full Text] [Related]
18. The Role of miRNA-182 and FOXO3 Expression in Breast Cancer.
Kandil NS; Kandil LS; Mohamed R; Selima M; El Nemr M; Barakat AR; Alwany YN
Asian Pac J Cancer Prev; 2022 Oct; 23(10):3361-3370. PubMed ID: 36308360
[TBL] [Abstract][Full Text] [Related]
19. MiRNA-409-5p dysregulation promotes imatinib resistance and disease progression in children with chronic myeloid leukemia.
Liu YY; Jiao WY; Li T; Bao YY
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8468-8475. PubMed ID: 31646577
[TBL] [Abstract][Full Text] [Related]
20. A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2.
Dai Y; Rahmani M; Corey SJ; Dent P; Grant S
J Biol Chem; 2004 Aug; 279(33):34227-39. PubMed ID: 15175350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]